No abstract

Background Patients with COVID‐19 can have central or peripheral neurological manifestations. Methods We report the case of two patients with acute cerebellar ataxia and myoclonus (ACAM) associated with COVID‐19 (with video) and discuss five previously reported patients. Results ACAM started between ten days and six weeks after the first manifestations of COVID‐19. Opsoclonus or ocular flutter was present in 4 patients. Patients were treated with intravenous immunoglobulins and/or steroids except for one patient, resulting in a striking improvement within a week. Conclusion ACAM with or without opsoclonus belongs to the wide spectrum of neurological manifestations associated with COVID19. It is important to recognize this possible manifestation since early treatment allows for rapid recovery.

No abstract